The World of Health & Medicine News

China Approves First Homegrown GLP-1 Obesity Drug, Challenging Global Giants

China Approves First Homegrown GLP-1 Obesity Drug, Challenging Global Giants

Chinese pharmaceutical company Hangzhou Jiuyuan Gene Engineering has received preliminary approval in China for Maibulin, an injectable GLP‑1 agonist weight‑loss drug, marking the country’s first homegrown competitor to Novo Nordisk’s Wegovy and Eli Lilly’s treatments.

This milestone empowers the company to introduce Maibulin in selected hospitals and clinics and aligns with China’s strategy to reduce dependency on imported medications by encouraging local production. With global demand for obesity drugs surging, the domestic rival could drive down prices and improve patient access.

 Moreover, as the patent on semaglutide expires in early 2026, companies like Innogen are accelerating late‑stage trials, underscoring an intensifying race among Chinese firms to offer affordable GLP‑1 therapies

spot_img

Explore more

spot_img

WHO launches bold push to raise health taxes and save millions...

WHO launches bold push to raise health taxes and save millions of lives The “3 by 35” Initiative targets tobacco, alcohol, and sugary drinks to...

US CDC accepts ousted vaccine panel’s recommendations for RSV, meningococcal shots

US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a...

NATO fund backs biotech startup in push to counter biological threats

NATO fund backs biotech startup in push to counter biological threats The NATO Innovation Fund has made its first investment in a biotechnology company, it...

It’s too easy to make AI chatbots lie about health information,...

It’s too easy to make AI chatbots lie about health information, study finds Well-known AI chatbots can be configured to routinely answer health queries with...

Innogen, Other Chinese Pharmas to Cause Weight-Loss Drug Price Plunge

Innogen, Other Chinese Pharmas to Cause Weight-Loss Drug Price Plunge Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug...

Should you drink ice water in hot weather?

Should you drink ice water in hot weather? Things are hotting up across the U.S. — this past week saw hundreds of record highs broken from...

Exclusive-USAID Cancelled Rape Survivor Kits for Congo as Conflict Erupted

Exclusive-USAID Cancelled Rape Survivor Kits for Congo as Conflict Erupted U.S. President Donald Trump's administration cancelled a major contract to supply emergency kits for rape...

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR...

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis  Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European...